SPRUCE BIOSCIENCES
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system. The company is driven by a mission to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal. They are committed to transforming the quality of life for patients who have been underserved by scientific innovation.
SPRUCE BIOSCIENCES
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sprucebiosciences.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
161.6 M USD
Technology used in webpage:
Pound Sterling Japanese Yen COVID-19 Akamai Hosted
Similar Organizations
Alpha Pharm
Alpha Pharm Tech is a pharmaceuticals company. It offers a wide range of services that ensures the patient receives a multitude of quality.
BELLWYCK Packaging Solutions
Bellwyck Packaging Solutions offers grading services for pharma, healthcare, cosmetics, fragrance, wine, spirits, and confectionery sectors.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Piton Therapeutics, Inc.
Piton employs a novel strategy to develop, first-in-class, precision therapeutics for chronic diseases and disorders.
Reset Therapeutics
Reset Therapeutics, a biopharmaceutical company, develops and commercializes products that modulate the circadian system of the human body.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Stock Details
Investors List
Abingworth
Abingworth investment in Post-IPO Equity - Spruce Biosciences
Rock Springs Capital
Rock Springs Capital investment in Post-IPO Equity - Spruce Biosciences
Armistice Capital
Armistice Capital investment in Post-IPO Equity - Spruce Biosciences
5AM Ventures
5AM Ventures investment in Post-IPO Equity - Spruce Biosciences
Novo Holdings
Novo Holdings investment in Post-IPO Equity - Spruce Biosciences
RiverVest
RiverVest investment in Post-IPO Equity - Spruce Biosciences
HealthCap
HealthCap investment in Post-IPO Equity - Spruce Biosciences
Omega Funds
Omega Funds investment in Series B - Spruce Biosciences
Abingworth
Abingworth investment in Series B - Spruce Biosciences
HealthCap
HealthCap investment in Series B - Spruce Biosciences
Key Employee Changes
Official Site Inspections
http://www.sprucebiosciences.com
- Host name: ip-173-201-184-73.ip.secureserver.net
- IP address: 173.201.184.73
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Spruce Biosciences"
Spruce Biosciences - Crunchbase Company Profile & Funding
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system. The company is driven by a mission to develop meaningful …See details»
Spruce Biosciences, Inc. (SPRB) - Yahoo Finance
See the company profile for Spruce Biosciences, Inc. (SPRB) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Spruce Biosciences - businessabc
Feb 25, 2025 Spruce Biosciences was founded in 2014 by scientists, industry veterans, and clinicians to bridge the gap between genetic technologies and treatments for patients with rare, …See details»
Documents & Charters - Spruce Biosciences
The Board of Directors of Spruce Biosciences (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of …See details»
Spruce Biosciences, Inc. - AnnualReports.com
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned …See details»
Spruce Biosciences - Org Chart, Teams, Culture & Jobs - The Org
Spruce Biosciences is a biopharma company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical need. Industries. Biotechnology. …See details»
Spruce Biosciences, Inc. (SPRB) Company Profile & Overview
Oct 9, 2020 Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in …See details»
Spruce Biosciences Company Profile - Office Locations ... - Craft
Oct 29, 2024 Spruce Biosciences has 4 employees across 2 locations and $10.09 m in annual revenue in FY 2023. See insights on Spruce Biosciences including office locations, …See details»
Spruce Biosciences - Overview, News & Similar companies
Who is Spruce Biosciences. Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with …See details»
Spruce Biosciences - Funding, Financials, Valuation & Investors
Spruce Biosciences is registered under the ticker NASDAQ:SPRB . Their stock opened with $15.00 in its Oct 9, 2020 IPO. Stock Symbol NASDAQ:SPRB ; Valuation at IPO $333.9M; …See details»
Spruce Biosciences Inc. Company Profile & Executives - WSJ
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant …See details»
Spruce Biosciences, Inc. (SPRB) - Yahoo Finance Canada
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in …See details»
Spruce Biosciences Information - RocketReach
The NAICS codes for Spruce Biosciences are [5417, 54, 541714, 54171, 541]. What is the SIC code for Spruce Biosciences? The SIC codes for Spruce Biosciences are [87, 873]. Top …See details»
Spruce Biosciences - 2025 Company Profile - Tracxn
Mar 6, 2025 Spruce Biosciences - Clinical stage biopharma developing rare diseases affecting the stress pathway (HPA axis). Public Company. Raised a total funding of $108M over 3 …See details»
Spruce Biosciences Reports Full Year 2022 Financial Results and ...
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical …See details»
Spruce Biosciences Inc, SPRB:NAQ profile - FT.com - Financial Times
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare endocrine disorders with significant unmet medical needs. …See details»
Spruce Biosciences Company Overview, Contact Details
Feb 9, 2023 Spruce Biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system. Sign up for free …See details»
Nextsource | Company Profile | Spruce Biosciences
Monitor if Spruce Biosciences is shifting their marketing strategy based on recent ad campaigns or rebranding efforts. See if Spruce Biosciences recently had any job openings or layoffs. …See details»
Spruce Biosciences | European Clinical Trials Information Network
Spruce Biosciences is a biopharmaceutical company that specializes in developing innovative therapies for endocrine diso. Menu. Search for Clinical Trials. Autoimmunity. Cancers. …See details»
Spruce Biosciences (SPRB) Earnings Date and Reports 2025
Mar 19, 2025 Spruce Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's …See details»